Mar 13, 2019 (AB Digital via COMTEX) -- The Global In-Vitro Fertilization Market is growing pervasively, mainly due to the presence of proper regulatory frameworks that have helped assisted reproduction technologies such as IVF to gain quick acceptance in developed as well as developing regions, globally.
Acknowledging the phenomenal growth prospect, the market is demonstrating currently; Market Research Future (MRFR), in its recently published analysis confirms that the global in-vitro fertilization market is set to witness a sound growth by 2023, registering a whopping CAGR throughout the forecast period (2015 – 2023).
Additional factors positively impacting market growth include the growing prevalence of infertility and gynecological disorders that are increasing every year.
The key strategies traced from the analysis of recent developments of the key players include agreement & partnership, product launch, acquisition, and expansion.
Key players leading the global in-vitro fertilization market include Cook Medical, Cooper Surgical Fertility, Oxford Gene Technology, INVO Bioscience, Merck KGaA, Thermo Fisher Scientific, Irvine Scientific, Genea Limited, Vitrolife, and Genea Biomedix.
March 04, 2019 - Lee Women’s Hospital (Taiwan), a prestigious reproductive medical center, introduced its latest in vitro fertilization (IVF) technology, that is known to increase the pregnancy success rate of infertile patients.
Sep 30, 2019 (AB Digital via COMTEX) -- The Global In-Vitro Fertilization Market size worth USD 12,700 Million with growing at a CAGR of 10.5% during the forecast period (2018-2023).
In-Vitro Fertilization (IVF) can be defined as a fertilization process, which generally takes place externally and involves the production of eggs, i.e., superovulation in women by injecting hormones and medication.
The eggs when matured, are removed from the ovary with the help of oocyte aspiration systems and is then fertilized with the donor’s sperm, which is later grown in the laboratory until it gets developed.
Meanwhile, in males, the deposit of fats decreases the level of testosterone, which results in decreased sperm production.
Based on the end users, the in-vitro fertilization market consists of fertility clinics, clinical research institutes, and hospitals.
Of these, the fertility clinics segment acquires the largest share in the global in-vitro fertilization market due to the increased number of fertility centers across the globe along with the rising fertility rates globally.
